Literature DB >> 29229430

Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial.

Robert Knoerl1, Ellen M L Smith2, Debra L Barton2, David A Williams3, Janean E Holden2, John C Krauss4, Beth LaVasseur5.   

Abstract

The purpose of this pilot, parallel, randomized controlled trial was to examine the efficacy of a self-guided online cognitive and behaviorally-based pain management intervention (Proactive Self-Management Program for Effects of Cancer Treatment [PROSPECT]) to reduce "worst" pain for individuals with chronic painful chemotherapy-induced peripheral neuropathy (CIPN). Secondary outcomes included "average" pain, nonpainful CIPN symptom severity, impression of change, and pain interference. Sixty patients with chronic painful CIPN were recruited from 5 outpatient academic and community cancer centers. Patients were randomized in a 1:1 ratio to receive either 8 weeks of PROSPECT or usual care. A 7-day electronic "worst" pain intensity diary and standardized measures of pain interference, nonpainful CIPN symptom severity, impression of change, and "average" pain were administered pre/post intervention. Postintervention mean scores were evaluated between groups using analysis of covariance adjusting for baseline. Individuals who received the PROSPECT intervention (n = 19) had significantly greater improvements in "worst pain" compared with individuals receiving usual care (n = 19; P = .046, d = .58). There were no significant differences in mean scores between groups for the secondary outcomes (n = 42). A larger, adequately powered study testing the PROSPECT intervention is needed to determine if improvements in pain may be sustained, evaluate the effect of the intervention on the secondary outcomes, and identify mediators of pain intensity-related improvement. PERSPECTIVE: This study explores the efficacy of an 8-week online cognitive behavioral pain management intervention for chronic painful CIPN. Intervention use resulted in greater improvements in "worst" pain than usual care alone. The findings provide preliminary support for the efficacy of a nonpharmacological intervention for chronic painful CIPN.
Copyright © 2017 The American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic pain; chemotherapy-induced peripheral neuropathy; cognitive-behavioral therapy; peripheral nervous system disease/chemically induced

Mesh:

Substances:

Year:  2017        PMID: 29229430     DOI: 10.1016/j.jpain.2017.11.009

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  11 in total

Review 1.  Prevention and Management of Chemotherapy-Induced Polyneuropathy.

Authors:  Berit Jordan; Franziska Jahn; Sandra Sauer; Karin Jordan
Journal:  Breast Care (Basel)       Date:  2019-04-10       Impact factor: 2.860

Review 2.  Pharmacological and Nonpharmacological Management of Chemotherapy-Induced Peripheral Neuropathy: A Scoping Review of Randomized Controlled Trials.

Authors:  Katie Fitzgerald Jones; Stephen Wechsler; David Zulewski; Lisa Wood
Journal:  J Palliat Med       Date:  2022-02-04       Impact factor: 2.947

Review 3.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

4.  Randomized Trial of a Tailored Cognitive-Behavioral Therapy Mobile Application for Anxiety in Patients with Incurable Cancer.

Authors:  Joseph A Greer; Jamie Jacobs; Nicole Pensak; James J MacDonald; Charn-Xin Fuh; Giselle K Perez; Alina Ward; Colleen Tallen; Alona Muzikansky; Lara Traeger; Frank J Penedo; Areej El-Jawahri; Steven A Safren; William F Pirl; Jennifer S Temel
Journal:  Oncologist       Date:  2019-01-25

5.  Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention.

Authors:  Robert Knoerl; Debra L Barton; Janean E Holden; John C Krauss; Beth LaVasseur; Ellen M L Smith
Journal:  Can Oncol Nurs J       Date:  2018-07-01

6.  Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.

Authors:  Robert Knoerl; Edie Weller; Barbara Halpenny; Donna Berry
Journal:  BMC Cancer       Date:  2018-12-04       Impact factor: 4.430

7.  The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.

Authors:  Cynthia S Bonhof; Lonneke V van de Poll-Franse; Dareczka K Wasowicz; Laurens V Beerepoot; Gerard Vreugdenhil; Floortje Mols
Journal:  J Cancer Surviv       Date:  2020-11-13       Impact factor: 4.442

Review 8.  Online Acceptance and Commitment Therapy (ACT) interventions for chronic pain: A systematic literature review.

Authors:  D L van de Graaf; H R Trompetter; T Smeets; F Mols
Journal:  Internet Interv       Date:  2021-10-01

Review 9.  Recent advances in understanding chemotherapy-induced peripheral neuropathy.

Authors:  Richard Gordon-Williams; Paul Farquhar-Smith
Journal:  F1000Res       Date:  2020-03-11

10.  Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.

Authors:  C S Bonhof; H R Trompetter; G Vreugdenhil; L V van de Poll-Franse; F Mols
Journal:  Support Care Cancer       Date:  2020-04-12       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.